The Business Research Company’s global market reports are now updated with the latest market sizing information for the year 2024 and forecasted to 2033

According to The Business Research Company’s Tuberculosis Diagnostics Global Market Report 2024, the tuberculosis diagnostics market is expected to show promising growth in the forecast period.

Exploring Market Growth

• Market size surged from $2.11 billion in 2023 to $2.27 billion in 2024.
• Expected to reach $3.02 billion by 2028 with a CAGR of 7.4%.

Understanding the Growth Drivers

Rising Incidence of Tuberculosis

• Tuberculosis infections increased by 9.4% in 2021 in the United States.
• Early diagnosis crucial for effective disease management.

Government Support and FDA Approvals

• Strong government backing and FDA approvals propel market growth.
• Increased focus on research and development activities.

Emergence of Drug-Resistant TB

• Growing concern over drug-resistant tuberculosis.
• Drives demand for advanced diagnostics and treatment methods.

View More On The Tuberculosis Diagnostics Market Report 2024 – https://www.thebusinessresearchcompany.com/report/tuberculosis-diagnostics-global-market-report

 Key Trends in Tuberculosis Diagnostics

Next-Generation Sequencing (NGS) Platforms

• NGS platforms gain prominence for TB diagnostics.
• Offers high accuracy and efficiency in testing.

T-Cell Tests for TB Infection

• T-cell tests emerge as a reliable diagnostic tool.
• Helps in the detection of latent tuberculosis.

Artificial Intelligence (AI)-Based Diagnostics

• AI-based solutions revolutionize tuberculosis diagnosis.
• Enhances accuracy and speed of diagnostic processes.

Portable Devices for Point-of-Care Testing

• Introduction of portable devices for on-the-spot testing.
• Offers convenience and accessibility in remote areas.

Government-Manufacturer Collaborations

• Collaborations drive innovation and market growth.
• Governments partner with manufacturers to address tuberculosis challenges.

Prominent Players in the Market

Industry Leaders

• Beckton, Dickinson and Company
• Hoffmann-La Roche Ltd.
• Qiagen N.V
• BioMerieux SA
• Danaher Corporation

Key Acquisition

• PerkinElmer acquires Oxford Immunotec for $591 million.
• Expands infectious disease testing solutions globally.

Segmentation of the Market

Test Type

• Radiographic Tests
• Nucleic Acid Testing
• Cytokine Detection Tests
• Drug Resistance Tests
• Skin Test or Mantoux Test (TST)
• Blood or Serology Test
• Smear Microscopy Tests
• Cell Culture-Based Tests
• Other Test Types

Disease Stage

• Latent Tuberculosis
• Active Tuberculosis

End-User

• Hospitals And Diagnostic Laboratories
• Physician’s Office Laboratories
• Reference Laboratories
• Academics And Research Facilities

Regional Dominance

Asia-Pacific Leads the Way

• Asia-Pacific emerges as the largest region in the tuberculosis diagnostics market in 2023.
• Significant advancements and investments contribute to market leadership.

As tuberculosis remains a global health concern, the advancements in diagnostics technologies pave the way for more effective disease management and control. With a focus on innovation, collaboration, and accessibility, the tuberculosis diagnostics market is poised to make significant strides in the coming years, offering hope in the fight against this infectious disease.

Request A Sample Of The Global Tuberculosis Diagnostics Market Report 2024:
https://www.thebusinessresearchcompany.com/sample_request?id=8165&type=smp